These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26179967)

  • 21. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension.
    Puato M; Palatini P; Zanardo M; Dorigatti F; Tirrito C; Rattazzi M; Pauletto P
    Hypertension; 2008 May; 51(5):1300-5. PubMed ID: 18378860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement.
    Matsui Y; Eguchi K; Ishikawa J; Hoshide S; Shimada K; Kario K
    Am J Hypertens; 2007 Apr; 20(4):385-91. PubMed ID: 17386344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
    Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA;
    Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home blood pressure in poorly controlled hypertension: relationship with ambulatory blood pressure and organ damage.
    Martínez MA; Sancho T; García P; Moreno P; Rubio JM; Palau FJ; Antón JL; Cirujano FJ; Sanz J; Puig JG;
    Blood Press Monit; 2006 Aug; 11(4):207-13. PubMed ID: 16810031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and target organ damage.
    Leiria LF; Severo MD; Ledur PS; Becker AD; Aguiar FM; Massierer D; Freitas VC; Schaan BD; Gus M
    J Diabetes; 2015 Sep; 7(5):699-707. PubMed ID: 25327439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.
    Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T
    Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement.
    Zhang L; Li Y; Wei FF; Thijs L; Kang YY; Wang S; Xu TY; Wang JG; Staessen JA
    Hypertension; 2015 Jun; 65(6):1258-65. PubMed ID: 25870194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study.
    Lande MB; Carson NL; Roy J; Meagher CC
    Hypertension; 2006 Jul; 48(1):40-4. PubMed ID: 16735644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure rhythmicity and visceral fat in children with hypertension.
    Niemirska A; Litwin M; Feber J; Jurkiewicz E
    Hypertension; 2013 Oct; 62(4):782-8. PubMed ID: 23959553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.
    Pickering TG; Miller NH; Ogedegbe G; Krakoff LR; Artinian NT; Goff D; ; ;
    Hypertension; 2008 Jul; 52(1):1-9. PubMed ID: 18497371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association.
    Pickering TG; Miller NH; Ogedegbe G; Krakoff LR; Artinian NT; Goff D; ; ;
    J Cardiovasc Nurs; 2008; 23(4):299-323. PubMed ID: 18596492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension.
    Cuspidi C; Marabini M; Lonati L; Sampieri L; Comerio G; Pelizzoli S; Leonetti G; Zanchetti A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1707-11. PubMed ID: 8903637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and predictors of white-coat response in patients with treated hypertension.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters.
    Konstantopoulou AS; Konstantopoulou PS; Papargyriou IK; Liatis ST; Stergiou GS; Papadogiannis DE
    J Hum Hypertens; 2010 Mar; 24(3):151-7. PubMed ID: 19571827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity and applicability of a new recording method for hypertension.
    Mas-Heredia M; Molés-Moliner E; González-de Paz L; Kostov B; Ortiz-Molina J; Mauri-Vázquez V; Menacho-Pascual I; Cararach-Salami D; Sierra-Benito C; Sisó-Almirall A
    Rev Esp Cardiol (Engl Ed); 2014 Sep; 67(9):717-23. PubMed ID: 25172067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White-coat and masked hypertension in children: association with target-organ damage.
    Stabouli S; Kotsis V; Toumanidis S; Papamichael C; Constantopoulos A; Zakopoulos N
    Pediatr Nephrol; 2005 Aug; 20(8):1151-5. PubMed ID: 15947982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of target-organ damage in adolescent white-coat and sustained hypertensives.
    Páll D; Juhász M; Lengyel S; Molnár C; Paragh G; Fülesdi B; Katona E
    J Hypertens; 2010 Oct; 28(10):2139-44. PubMed ID: 20616755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.